Durand M - Search Results

1

Calpain3 expression during human cardiogenesis.

Fougerousse F, Anderson LV, Delezoide AL, Suel L, Durand M, Beckmann JS. Fougerousse F, et al. Among authors: durand m. Neuromuscul Disord. 2000 Jun;10(4-5):251-6. doi: 10.1016/s0960-8966(99)00107-8. Neuromuscul Disord. 2000. PMID: 10838251

2

Six and Eya expression during human somitogenesis and MyoD gene family activation.

Fougerousse F, Durand M, Lopez S, Suel L, Demignon J, Thornton C, Ozaki H, Kawakami K, Barbet P, Beckmann JS, Maire P. Fougerousse F, et al. Among authors: durand m. J Muscle Res Cell Motil. 2002;23(3):255-64. doi: 10.1023/a:1020990825644. J Muscle Res Cell Motil. 2002. PMID: 12500905

3

Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development.

Fougerousse F, Durand M, Suel L, Pourquié O, Delezoide AL, Romero NB, Abitbol M, Beckmann JS. Fougerousse F, et al. Among authors: durand m. Genomics. 1998 Mar 1;48(2):145-56. doi: 10.1006/geno.1997.5160. Genomics. 1998. PMID: 9521867

4

Human-mouse differences in the embryonic expression patterns of developmental control genes and disease genes.

Fougerousse F, Bullen P, Herasse M, Lindsay S, Richard I, Wilson D, Suel L, Durand M, Robson S, Abitbol M, Beckmann JS, Strachan T. Fougerousse F, et al. Among authors: durand m. Hum Mol Genet. 2000 Jan 22;9(2):165-73. doi: 10.1093/hmg/9.2.165. Hum Mol Genet. 2000. PMID: 10607827

5

Sequential expression of genes involved in muscular dystrophies during human development.

Durand M, Suel L, Barbet JP, Beckmann JS, Fougerousse F. Durand M, et al. Morphologie. 2002 Jun;86(273):9-12. Morphologie. 2002. PMID: 12224393

6

Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.

Fougerousse F, Gonin P, Durand M, Richard I, Raymackers JM. Fougerousse F, et al. Among authors: durand m. Muscle Nerve. 2003 May;27(5):616-23. doi: 10.1002/mus.10368. Muscle Nerve. 2003. PMID: 12707983

7

The muscle-specific enolase is an early marker of human myogenesis.

Fougerousse F, Edom-Vovard F, Merkulova T, Ott MO, Durand M, Butler-Browne G, Keller A. Fougerousse F, et al. Among authors: durand m. J Muscle Res Cell Motil. 2001;22(6):535-44. doi: 10.1023/a:1015008208007. J Muscle Res Cell Motil. 2001. PMID: 12038587

8

Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: durand m. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Mol Ther. 2007. PMID: 17164775 Free article.

9

Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.

Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Fougerousse F, et al. Among authors: durand m. Mol Ther. 2007 Jan;15(1):53-61. doi: 10.1038/sj.mt.6300022. Epub 2016 Dec 8. Mol Ther. 2007. PMID: 28182933

10

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.

Buj-Bello A, Fougerousse F, Schwab Y, Messaddeq N, Spehner D, Pierson CR, Durand M, Kretz C, Danos O, Douar AM, Beggs AH, Schultz P, Montus M, Denèfle P, Mandel JL. Buj-Bello A, et al. Among authors: durand m. Hum Mol Genet. 2008 Jul 15;17(14):2132-43. doi: 10.1093/hmg/ddn112. Epub 2008 Apr 22. Hum Mol Genet. 2008. PMID: 18434328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,749 results

Search Page